BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10549374)

  • 21. Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B.
    Liang KH; Hsu CW; Chang ML; Chen YC; Lai MW; Yeh CT
    J Infect Dis; 2016 Mar; 213(6):966-74. PubMed ID: 26582959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history and prognosis of hepatitis B.
    Fattovich G
    Semin Liver Dis; 2003 Feb; 23(1):47-58. PubMed ID: 12616450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summaries for patients. Combination therapy for chronic hepatitis B.
    Ann Intern Med; 2005 Feb; 142(4):I30. PubMed ID: 15710953
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New insight for HBV DNA and HBsAg quantitation during antiviral therapy in patients with chronic hepatitis B].
    Cho YK; Song BC
    Korean J Gastroenterol; 2011 Mar; 57(3):144-9. PubMed ID: 21519161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of hepatitis B therapy on the long-term outcome of liver disease.
    Liaw YF
    Liver Int; 2011 Jan; 31 Suppl 1():117-21. PubMed ID: 21205148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF
    Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
    Wong GL
    J Gastroenterol Hepatol; 2012 Jan; 27(1):1-2. PubMed ID: 22188022
    [No Abstract]   [Full Text] [Related]  

  • 35. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
    Warner N; Locarnini S
    Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
    [No Abstract]   [Full Text] [Related]  

  • 36. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
    Wu SY; Lan SH; Liu HS
    World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hepatitis B virus infection: treatment strategies for the next millennium.
    Malik AH; Lee WM
    Ann Intern Med; 2000 May; 132(9):723-31. PubMed ID: 10787366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: current antiviral therapy of chronic hepatitis B.
    Ayoub WS; Keeffe EB
    Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Looking to the future: new agents for chronic hepatitis B.
    Dienstag JL
    Am J Gastroenterol; 2006; 101 Suppl 1():S19-25. PubMed ID: 16448448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.